BGM Group Ltd. BGM
NASDAQ BGM
$8.24 -0.73 (-8.14%)
As of: Oct 21, 2026 · 10:14 AM EDT

Bgm (BGM) Convertible Debt (2024 - 2025)

Updated

Bgm (BGM) recorded Convertible Debt of -$7.7 million in fiscal Q4 2025 (quarter ended Sep 30, 2025), compared with -$819,432 a year earlier.

Analysis

Bgm (BGM) Convertible Debt (2024 - 2025) Analysis & Trends

  • Across earlier fiscal years, Convertible Debt came in at -$819,432 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,152.37 Bn 1,120.96 Bn 19.71 Bn
2 Johnson & Johnson 628.86 Bn 547.39 Bn 17.26 Bn
3 AbbVie 500.37 Bn 473.48 Bn 12.70 Bn
4 Merck 374.01 Bn 328.39 Bn 12.21 Bn
5 Novartis Ag 300.56 Bn 264.55 Bn 11.24 Bn
6 Astrazeneca 263.92 Bn 237.60 Bn 12.86 Bn
7 Amgen 238.37 Bn 193.77 Bn 7.24 Bn
8 Gilead Sciences 192.21 Bn 166.40 Bn 6.22 Bn
9 Pfizer 171.20 Bn 117.84 Bn 10.94 Bn
10 Bgm 32.47 Mn -21.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -7.70 Mn
Sep 30, 2024 -819,432.00
API Access

Bgm Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=BGM&period=max&api_key=YOUR_API_KEY